AUG 13, 2026 · PHASE 3 TRIAL
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov
This is a clinical trial registry record describing a Phase 3 study that is currently recruiting with no results posted; it documents planned design and endpoints only.
Reported
Planned enrollment1160
Study phasePhase 3
Primary outcome measure 1Overall survival (OS), up to approximately…